Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014638 · ClinicalTrials.gov registry record · Phase 4
Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
A Phase 4 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00014638 is a Phase 4 study that has completed, run by Novartis.
The verdict
NCT00014638, a Phase 4 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
RATIONALE: Estrogen can stimulate the growth of cancer cells. Letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: Phase IV trial to study the effectiveness of letrozole in treating postmenopausal women who have metastatic breast cancer that has been previously treated with tamoxifen.
Interventions
- DRUG letrozole
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2002-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00014638
The ClinicalTrials.gov registry entry for NCT00014638 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which letrozole is the first listed.
NCT00014638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00014638 about?
NCT00014638 is a clinical study titled "Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer". RATIONALE: Estrogen can stimulate the growth of cancer cells. Letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: Phase IV trial to study the effectiveness of letrozole in treating postmenopausal women who have metastatic breast cancer that has been previously treated...
What is the current status of trial NCT00014638?
This trial is currently completed. It is a Phase 4 study. The study started on 2001-01. Estimated completion is 2002-03.
What interventions are being tested in trial NCT00014638?
The interventions under investigation include: letrozole (DRUG).
Who is sponsoring clinical trial NCT00014638?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.